Charles Stucki

Individuals, businesses, and industries can work better with blockchain technology. BlockApps is the leader in Web3Commerce. We unlock the value of real-world assets by making them more trusted, transparent, and fair.

OtoNexus Medical Technologies is revolutionizing the diagnosis and management of middle ear infections. The OtoNexus technology platform harnesses the power of ultrasound technology to rapidly and accurately determine both the presence and the type of fluid behind the eardrum, providing a superior alternative to outdated diagnostic methods. By accurately determining the type of infection, healthcare providers can avoid prescribing antibiotics when they are not needed, helping to combat the growing issues of antibiotic resistance. Accurate diagnoses and appropriate treatment could reduce healthcare costs by minimizing complications and the need for additional treatments or follow-up visits. Patients will benefit from a faster, non-invasive diagnostic procedure, leading to quicker treatment and potentially shorter recovery times. Healthcare providers will benefit from a reliable and easy-to-use tool that enhances their diagnostic capabilities and supports their decision-making process. One-use-per-patient proprietary disposable tips incorporating this new patented ultrasound technology create a recurring revenue stream. The device is a simple, affordable, portable, lightweight, non-invasive tool that provides data in 1-2 seconds on the type of middle ear infection. With this information, healthcare providers can accurately assess middle ear infections and responsibly treat them with antibiotics when appropriate.

Join fuses wired and wireless networking with Secure Access Service Edge into Graphite™, the first unified Secure Agentic Networking Platform. Powered by AgenticOps and delivered on OpenLAN standard hardware, Graphite’s novel architecture delivers superior business outcomes with best in class reliability and performance. Join’s modular approach allows customers to respond flexibly to their business priorities, implementing the elements of the platform they need today, while seamlessly growing their implementation as their needs evolve. The result is industry-leading contextual, real-time telemetry and observability that automates network operations and reduces operational complexity.

Founded in 2017, Deepen AI is the only safety-first data lifecycle tools and services company focused on unlocking the potential of machine learning and AI for autonomous systems. Our tools and services are customizable to suit the needs of enterprises as well as start-ups.

LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Light™ to offer a comprehensive approach for detecting, treating, and monitoring retinal diseases, specifically dry age-related macular degeneration (AMD). LumiThera is the leader in ophthalmic photobiomodulation (PBM) innovation with its flagship product, the Valeda® Light Delivery System. Multiwavelength Valeda treatments are for patients suffering from dry AMD. Valeda is FDA Authorized in the US, CE Marked in the EU, and available in select countries in Latin America. AdaptDx Pro® is a portable dark adaptometer that utilizes AI to deliver a uniform patient experience. AdaptDx Pro is available in the U.S. and Canada. NOVA Vision Testing System is a comprehensive electrophysiology platform that provides objective assessment of the entire pathway for visual and neuro-visual disorders. VEP is available in the U.S. and select countries outside of the U.S. ERG is only available outside of the U.S. For more information on Valeda, visit www.lumithera.com. AdaptDx Pro and NOVA are available through LumiThera Diagnostics, Inc. and Diopsys, Inc., respectively.

Request Network, an EVM-compatible infrastructure protocol, is designed to cater to various Web3 financial applications, including invoicing, payments, accounting, and under-collateralized loans. It enhances blockchain transactions by appending extra data and facilitating compliance, reconciliation, and traceability. The infrastructure empowers users to maintain ownership of their financial data, with the flexibility to transfer and selectively share it. Learn more from our developer documentation - https://docs.request.network/ For current openings - https://request.network/foundation Get in touch with the team - https://request.network/discord #fairness #crypto #cryptoinvoicing #reputation $USDC $USDT $DAI #invoice #blockchain #fintech #ethereum #bitcoin

Individuals, businesses, and industries can work better with blockchain technology. BlockApps is the leader in Web3Commerce. We unlock the value of real-world assets by making them more trusted, transparent, and fair.

OtoNexus Medical Technologies is revolutionizing the diagnosis and management of middle ear infections. The OtoNexus technology platform harnesses the power of ultrasound technology to rapidly and accurately determine both the presence and the type of fluid behind the eardrum, providing a superior alternative to outdated diagnostic methods. By accurately determining the type of infection, healthcare providers can avoid prescribing antibiotics when they are not needed, helping to combat the growing issues of antibiotic resistance. Accurate diagnoses and appropriate treatment could reduce healthcare costs by minimizing complications and the need for additional treatments or follow-up visits. Patients will benefit from a faster, non-invasive diagnostic procedure, leading to quicker treatment and potentially shorter recovery times. Healthcare providers will benefit from a reliable and easy-to-use tool that enhances their diagnostic capabilities and supports their decision-making process. One-use-per-patient proprietary disposable tips incorporating this new patented ultrasound technology create a recurring revenue stream. The device is a simple, affordable, portable, lightweight, non-invasive tool that provides data in 1-2 seconds on the type of middle ear infection. With this information, healthcare providers can accurately assess middle ear infections and responsibly treat them with antibiotics when appropriate.

Join fuses wired and wireless networking with Secure Access Service Edge into Graphite™, the first unified Secure Agentic Networking Platform. Powered by AgenticOps and delivered on OpenLAN standard hardware, Graphite’s novel architecture delivers superior business outcomes with best in class reliability and performance. Join’s modular approach allows customers to respond flexibly to their business priorities, implementing the elements of the platform they need today, while seamlessly growing their implementation as their needs evolve. The result is industry-leading contextual, real-time telemetry and observability that automates network operations and reduces operational complexity.

Founded in 2017, Deepen AI is the only safety-first data lifecycle tools and services company focused on unlocking the potential of machine learning and AI for autonomous systems. Our tools and services are customizable to suit the needs of enterprises as well as start-ups.

LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Light™ to offer a comprehensive approach for detecting, treating, and monitoring retinal diseases, specifically dry age-related macular degeneration (AMD). LumiThera is the leader in ophthalmic photobiomodulation (PBM) innovation with its flagship product, the Valeda® Light Delivery System. Multiwavelength Valeda treatments are for patients suffering from dry AMD. Valeda is FDA Authorized in the US, CE Marked in the EU, and available in select countries in Latin America. AdaptDx Pro® is a portable dark adaptometer that utilizes AI to deliver a uniform patient experience. AdaptDx Pro is available in the U.S. and Canada. NOVA Vision Testing System is a comprehensive electrophysiology platform that provides objective assessment of the entire pathway for visual and neuro-visual disorders. VEP is available in the U.S. and select countries outside of the U.S. ERG is only available outside of the U.S. For more information on Valeda, visit www.lumithera.com. AdaptDx Pro and NOVA are available through LumiThera Diagnostics, Inc. and Diopsys, Inc., respectively.